Compare GLW & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLW | GSK |
|---|---|---|
| Founded | 1851 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | 66841 |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.7B | 108.7B |
| IPO Year | 2008 | N/A |
| Metric | GLW | GSK |
|---|---|---|
| Price | $176.85 | $53.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 2 |
| Target Price | ★ $146.91 | N/A |
| AVG Volume (30 Days) | ★ 10.2M | 3.5M |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | 0.74% | ★ 3.40% |
| EPS Growth | ★ 215.52 | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $15,629,000,000.00 | N/A |
| Revenue This Year | $20.74 | $6.99 |
| Revenue Next Year | $12.80 | $4.19 |
| P/E Ratio | $391.35 | ★ $32.75 |
| Revenue Growth | ★ 19.14 | N/A |
| 52 Week Low | $49.47 | $35.45 |
| 52 Week High | $211.79 | $61.70 |
| Indicator | GLW | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 47.73 | 58.96 |
| Support Level | $171.11 | $48.02 |
| Resistance Level | $177.92 | $59.97 |
| Average True Range (ATR) | 11.93 | 0.76 |
| MACD | -3.11 | 0.35 |
| Stochastic Oscillator | 26.07 | 98.25 |
Corning is a provider of glass, ceramics, and optical fiber across six distinct end markets. Corning's largest segments by revenue are display glass for TVs and optical fiber for telecom networks and data centers. It also provides cover glass for smartphones as well as filters and substrates and glass for cars, produces pharmaceutical glass, and produces polysilicon for solar panels. Corning is a US producer and is vertically integrated across its products and markets.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.